Mather Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-5
Closed -$37 1859
2024
Q2
$37 Buy
+5
New +$37 ﹤0.01% 2169